Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Banyu reports synthesis and activity of BE-39907A2

April 12, 1996

Banyu discovers new thioredoxin system inhibitor

April 12, 1996

Isis, Ciba-Geigy evaluate antisense drug in phase I

April 12, 1996

Gastrimmune phase I/II trial completed

April 12, 1996

Seed implant treatment effective in prostate cancer

April 5, 1996

Scotia accelerates development of temoporfin

April 5, 1996

Lu-Tex clinical update

April 5, 1996

New antitumor proteins from Alfacell

April 5, 1996

Oncogene Science, Pfizer extend research agreement

April 5, 1996

New telomerase inhibitor from Geron

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...